| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Addressing the ethical challenges in genetic testing and sequencing of children.
|
Am J Bioeth
|
2014
|
7.34
|
|
2
|
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group.
|
Circ Cardiovasc Genet
|
2010
|
6.74
|
|
3
|
Incidental findings in imaging research: evaluating incidence, benefit, and burden.
|
Arch Intern Med
|
2010
|
3.40
|
|
4
|
Recommendations for returning genomic incidental findings? We need to talk!
|
Genet Med
|
2013
|
3.23
|
|
5
|
Ethics. Incidental findings in brain imaging research.
|
Science
|
2006
|
3.10
|
|
6
|
The big picture on nanomedicine: the state of investigational and approved nanomedicine products.
|
Nanomedicine
|
2012
|
1.83
|
|
7
|
Return of results in genomic biobank research: ethics matters.
|
Genet Med
|
2013
|
1.20
|
|
8
|
Incidental findings in CT colonography: literature review and survey of current research practice.
|
J Law Med Ethics
|
2008
|
1.16
|
|
9
|
An integrated approach to oversight assessment for emerging technologies.
|
Risk Anal
|
2008
|
1.15
|
|
10
|
Assessing physician compliance with the rules for euthanasia and assisted suicide.
|
Arch Intern Med
|
2005
|
1.10
|
|
11
|
The incidentalome.
|
JAMA
|
2006
|
1.08
|
|
12
|
The challenge of informed consent and return of results in translational genomics: empirical analysis and recommendations.
|
J Law Med Ethics
|
2014
|
1.01
|
|
13
|
Ethics committees and due process: nesting rights in a community of caring.
|
MD Law Rev
|
1991
|
0.99
|
|
14
|
Toward a theory of process.
|
Law Med Health Care
|
1992
|
0.97
|
|
15
|
Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field.
|
J Law Med Ethics
|
2012
|
0.87
|
|
16
|
Mapping the inputs, analyses, and outputs of biobank research systems to identify sources of incidental findings and individual research results for potential return to participants.
|
Genet Med
|
2012
|
0.86
|
|
17
|
Trying not to talk forever: a tool for change.
|
Law Med Health Care
|
1989
|
0.84
|
|
18
|
Developing U.S. oversight strategies for nanobiotechnology: learning from past oversight experiences.
|
J Law Med Ethics
|
2009
|
0.81
|
|
19
|
Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.
|
Am J Hum Genet
|
2016
|
0.77
|
|
20
|
Preimplantation testing to produce an HLA-matched donor infant.
|
JAMA
|
2004
|
0.76
|
|
21
|
The new world of genomic testing, families and privacy.
|
Minn Med
|
2015
|
0.75
|
|
22
|
Bioethics and law symposium: deconstructing traditional paradigms in bioethics: race, gender, class, and culture. Foreword: bioethics -- from mirror to window.
|
St Louis Univ Public Law Rev
|
1996
|
0.75
|
|
23
|
Practicing the PSDA.
|
Hastings Cent Rep
|
1992
|
0.75
|
|
24
|
Holding the line on euthanasia.
|
Hastings Cent Rep
|
1989
|
0.75
|
|
25
|
What Adrienne knew: living bioethics.
|
Hastings Cent Rep
|
2014
|
0.75
|
|
26
|
Introduction: The challenge of developing oversight approaches to nanobiotechnology.
|
J Law Med Ethics
|
2009
|
0.75
|
|
27
|
Euthanasia and the care of cancer patients.
|
J Clin Oncol
|
1994
|
0.75
|
|
28
|
Understanding the role of genetics in disability insurance.
|
J Law Med Ethics
|
2007
|
0.75
|